GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (OTCPK:FSPKF) » Definitions » Cash Flow from Operations

Fisher & Paykel Healthcare (Fisher & Paykel Healthcare) Cash Flow from Operations : $240 Mil (TTM As of Sep. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Fisher & Paykel Healthcare Cash Flow from Operations?

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the six months ended in Sep. 2023, Fisher & Paykel Healthcare's Cash Receipts from Operating Activities was $472 Mil. Its Cash Payments was $-359 Mil. Its Dividends Paid was $0 Mil. Its Dividends Received was $0 Mil. Its Interest Paid was $-5 Mil. Its Interest Received was $1 Mil. Its Taxes Refund Paid was $-17 Mil. And its Cash Flow from Others was $-0 Mil. In all, Fisher & Paykel Healthcare's Cash Flow from Operations for the six months ended in Sep. 2023 was $93 Mil.


Fisher & Paykel Healthcare Cash Flow from Operations Historical Data

The historical data trend for Fisher & Paykel Healthcare's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare Cash Flow from Operations Chart

Fisher & Paykel Healthcare Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cash Flow from Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 173.14 194.67 446.32 222.73 147.86

Fisher & Paykel Healthcare Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 89.92 135.17 1.12 146.68 92.82

Fisher & Paykel Healthcare Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Fisher & Paykel Healthcare's Cash Flow from Operations for the fiscal year that ended in Mar. 2023 is calculated as:

Fisher & Paykel Healthcare's Cash Flow from Operations for the quarter that ended in Sep. 2023 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $240 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fisher & Paykel Healthcare  (OTCPK:FSPKF) Cash Flow from Operations Explanation

For non-financial companies reported in direct method, cash flow from operations contains eight items:

1. Cash Receipts from Operating Activities:
Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method.

Fisher & Paykel Healthcare's cash receipts from operating activities for the six months ended in Sep. 2023 was $472 Mil.

2. Cash Payments:
It represents cash flow paid from operating activities in the direct cash flow method.

Fisher & Paykel Healthcare's cash payments for the six months ended in Sep. 2023 was $-359 Mil.

3. Dividends Paid:
It represents dividend paid to the investors in the direct cash flow method.

Fisher & Paykel Healthcare's cash payments for the six months ended in Sep. 2023 was $0 Mil.

4. Dividends Received:
It represents dividend received on the investment in the direct cash flow method.

Fisher & Paykel Healthcare's cash payments for the six months ended in Sep. 2023 was $0 Mil.

5. Interest Paid:
It represents interest paid on loans, debt or borrowings, in the direct cash flow method.

Fisher & Paykel Healthcare's cash payments for the six months ended in Sep. 2023 was $-5 Mil.

6. Interest Received:
It represents interest received by the company in the direct cash flow method.

Fisher & Paykel Healthcare's cash payments for the six months ended in Sep. 2023 was $1 Mil.

7. Taxes Refund Paid:
It represents tax paid or refund related to operating activities in the direct cash flow method.

Fisher & Paykel Healthcare's cash payments for the six months ended in Sep. 2023 was $-17 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of cash receipts and cash payments. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its cash position will grow more slowly (or even shrink).

Fisher & Paykel Healthcare's cash flow from others for the six months ended in Sep. 2023 was $-0 Mil.


Fisher & Paykel Healthcare Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Fisher & Paykel Healthcare (Fisher & Paykel Healthcare) Business Description

Traded in Other Exchanges
Address
15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.

Fisher & Paykel Healthcare (Fisher & Paykel Healthcare) Headlines

From GuruFocus

Fisher & Paykel Healthcare Corp Ltd's Dividend Analysis

By GuruFocus Research 12-04-2023